Osmitrol in Aviva
"WASHINGTON, DC â€” The Micra Transcatheter Pacing System by Medtronic has become the first leadless pacemaker system to be approved in the United States. The US Food and Drug Administration (FDA) announced the approval almost 2 months afte"...
Osmitrol Injection in Aviva
Osmitrol Injection (Mannitol Injection, USP) is contraindicated in patients with:
Well established anuria due to severe renal disease, severe pulmonary congestion or frank pulmonary edema, active intracranial bleeding except during craniotomy, severe dehydration, Progressive renal damage or dysfunction after institution of mannitol therapy, including increasing oliguria and azotemia, and progressive heart failure or pulmonary congestion after institution of mannitol therapy.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 3/4/2009
Additional Osmitrol Injection in Aviva Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.